ARKG vs VXUS
ARK Genomic Revolution ETF vs Vanguard Total International Stock ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
VXUS—
Vanguard Total International Stock ETF
All non-US equities (developed + emerging).
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | VXUS |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
Holdings data unavailable for ARKG.
VXUS top holdings
Holdings data unavailable for VXUS.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About VXUS
VXUS (Vanguard Total International Stock ETF) is All non-US equities (developed + emerging).